Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing-Reference-Cited by-同舟云学术

Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing

Published:2020-12-11 Issue:50 Volume:6 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Abelson Sagi¹²^ORCID,Zeng Andy G. X.²³,Nofech-Mozes Ido¹²^ORCID,Wang Ting Ting³⁴,Ng Stanley W. K.⁵,Minden Mark D.³⁴^ORCID,Pugh Trevor J.¹³⁴^ORCID,Awadalla Philip¹²,Shlush Liran I.⁶⁷,Murphy Tracy³,Chan Steven M.³⁴^ORCID,Dick John E.²³^ORCID,Bratman Scott V.³⁴⁸^ORCID

Affiliation:

1. Ontario Institute for Cancer Research, Toronto, ON, Canada.

2. Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.

3. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

4. Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

5. Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.

6. Division of Hematology, Rambam Healthcare Campus, Haifa, Israel.

7. Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

8. Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.

Abstract

Espresso efficiently distinguishes true mutations from background noise common in deep sequencing data.

Funder

Genome Canada

Canadian Cancer Society Research Institute

Terry Fox Foundation

Canadian Institutes for Health Research

Benjamin Pearl fellowship, the McEwen Centre for Regenerative Medicine

Ontario Institute for Cancer Research - Investigator Award

Princess Margaret Cancer Centre - Gattuso-Slaight Personalized Cancer Medicine Fund

CIHR Vanier Scholarship

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference55 articles.

1. The Cancer Genome Atlas Pan-Cancer analysis project

2. International network of cancer genome projects

3. Comprehensive Characterization of Cancer Driver Genes and Mutations

4. Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types

5. Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidation of clinical implications Arising from circadian rhythm and insights into the tumor immune landscape in breast cancer;Heliyon;2024-03

2. BayVarC: an ultra-sensitive ctDNA variant caller using Bayesian approach;2024-02-07

3. Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker;Frontiers in Genetics;2023-01-04

4. SmMIP-tools: a computational toolset for processing and analysis of single-molecule molecular inversion probes-derived data;Bioinformatics;2022-02-12

5. Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA;Cell Reports Methods;2021-11